XML 22 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1

Stockholders' Deficiency

9 Months Ended

Sep. 30, 2018

Equity:

Stockholders' Deficiency

Note 6 – Stockholders’ Deficiency

Warrants

A summary of warrants issued, exercised and expired during the nine months ended September 30, 2018 is as follows:

		Shares				Weighted Average Exercise Price				Intrinsic Value
Balance at December 31, 2017			3,675,000			$	.15			$	45,000
Issued			—				—				—
Cancelled (replaced with Common Stock Options)			(2,300,000	)		$	.15				—
Balance at September 30, 2018			1,375,000			$	.14			$	—

X

- References

No definition available.

+ Details

Name:	pwvi_EquityAbstract1
Namespace Prefix:	pwvi_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

+ Details

Name:	us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration